21st Century President Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
99pct
589d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
21st Century President Act This act revises the definition of immediate family for purposes of a criminal offense involving a threat to kill, kidnap, or inflict bodily harm on a former President or a member of the immediate family of a former President. Specifically, it replaces gender-specific references to a former President's wife and widow with the gender-neutral terms spouse and surviving spouse .
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2024 · first_quarter · Medicare/Medicaid
Became Public Law No: 117-272.
Became Public Law No: 117-272.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S9610)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · second_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits H.R.2666 -- Medicaid MVP for Patients Act S.652 / H.R.2630 -- Safe Step Act H.R.2679 -- Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.3799 - CHOICE Arrangement Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
Client expense: $3,402,542 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · second_quarter · Health Issues
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2666 - Medicaid MVP for Patients Act S.652 / H.R.2630 - Safe Step Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act S.954 / H.R.1488 - Affordable Insulin Now Act H.R.1503 - Prescription Information Modernization Act H.R.1352 - Increasing Access to Biosimilars Act S.1374 - Patient Right to Shop Act H.R.3799 - CHOICE Arrangement Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.574 - Increasing Prescription Drug Competition Act S.775 - Increasing Transparency in Generic Drug Applications Act H.R.1790 - Biologics Competition Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1522 - A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
Client expense: $3,402,542 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · second_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 830/ S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2500: Protecting Americans from Unsafe Drugs Act of 2023 H.R. 2679: Pharmacy Benefit Manager Accountability Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2940/S 1355 PASTEUR Act/Incentives to increase novel antibiotic medicines H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3008: Drug Shortage Prevention Act of 2023 H.R. 3281: Transparent PRICE Act H.R. 3285: Fairness for Patient Medications Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program/Transparency Legislation H.R. 3433: Give Kids a Chance Act of 2023 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3791: Improving DATA in Public Health Act H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023 H.R. 3810: Drug Origin Transparency Act of 2023 H.R. 4390: Protect 340B Act - Provisions related to 340B Program (117th Congress) H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169)/Implementation of $0 Vaccine co-pay; maximum fair price provisions H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 - This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why) (117th Congress) H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022 (117th Congress) S. 6: Biosimilar Red Tape Elimination Act (117th Congress) S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes. S. 476: Maintaining Investments in New Innovation Act S. 775: Increasing Transparency in Generic Drug Applications Act S. 1128: Ensuring Access to Generic Medications Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 - Provisions related to drug pricing (117th Congress) S. 1967: Patients Before Middlemen (PBM Act) S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1114: Expanding Access to Low-Cost Generics Act 2023 S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act (117th Congress) Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues Cybersecurity policy issues Anticounterfeiting policy issues Chronic Kidney Disease Improvement in Research and Treatment Act. H.R.2534 - PROTECT 340B Act of 2023 House Draft Language for PAHPA Reauthorization HR 3665 - Defending American Jobs and Investment Act Senate Draft Language for PAHPA Reauthorization Pandemic and All Hazards Preparedness Act reauthorization (discussion draft) Labor HHS appropriations (ongoing discussion) Under Taxed Profit Rule, Ways and Means Committee discussion Vaccine Injury Compensation Program reform discussion
2023 · second_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2500: Protecting Americans from Unsafe Drugs Act of 2023 H.R. 2534: PROTECT 340B Act of 2023 - Provisions related to the 340B program H.R. 2679: Pharmacy Benefit Manager Accountability Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3008: Drug Shortage Prevention Act of 2023 H.R. 3281: Transparent PRICE Act H.R. 3285: Fairness for Patient Medications Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3433: Give Kids a Chance Act of 2023 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3791: Improving DATA in Public Health Act H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023 H.R. 3810: Drug Origin Transparency Act of 2023 H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 (117th Congress) H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022 (117th Congress) S. 6: Biosimilar Red Tape Elimination Act (117th Congress) S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes S. 476: Maintaining Investments in New Innovation Act S. 775: Increasing Transparency in Generic Drug Applications Act S. 1128: Ensuring Access to Generic Medications Act S. 935: Fair Accountability and Innovative Research Drug Pricing Act of 2023 - Provisions related to drug pricing S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1114: Expanding Access to Low-Cost Generics Act 2023 S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act (117th Congress) Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues Cybersecurity policy issues Anticounterfeiting policy issues
2023 · second_quarter · Health Issues
Legislative End of National Emergency (COVID-19) - H.J.Res.7, Public Law No: 118-3 Coverage of recommended preventative services -Affordable Care Acts (ACA) preventative services requirement, Braidwood v. Becerra ruling Pharmacy Benefit Manager (PBM) legislation including the PBM Reform Act - S. 1339 Safe Step Act - S. 652 Site-Based Invoicing and Transparency Enhancement (SITE) Act - S. 1869 Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 - H.R. 3561 Transparent PRICE Act - H.R. 3281 Fairness for Patients Medications Act - H.R. 3285 Facilitating Accountability in Reimbursements Act (FAIR Act) - H.R. 3417 Chronic Disease Flexible Coverage Act - H.R. 3800 Mental Health Matters Act - (H.R. 7780) (117th Congress) Health Network and Directory Improvement Act - S. 5093 Healthcare Workforce Shortage - request for information (RFI), Senate Health, Education, Labor and Pensions (HELP) Committee Healthy Competition for Better Care Act - S. 3139 (118th Congress) Telehealth Expansion Act - S, 1001/H.R. 1843 HSA Telehealth Extension Telehealth Benefit Expansion for Workers Act - H.R. 824 Employer-sponsored health coverage Site-Neutral Payment Reform Hospital Billing Practices Mental health parity Health cost transparency Dependent Care Flexible Spending Accounts (FSAs) Health Flexible Spending Accounts (FSAs) Health Savings Accounts (HSAs) Chronic Disease Management Prescription drug legislation Surprise billing regulations Health Equity ERISA preemption Regulatory White House - End of Public Health Emergency (PHE) and National Emergency (NE) Department of Health (HHS), Department of Labor (Labor) and Department of Treasury (Treasury) - (the tri-agencies) - guidance issued on end of COVID-19 Public Health Emergency (PHE) and National Emergency (NE) Centers for Medicare and Medicaid Services (CMS) - comment letter underscoring importance of Medicare Advantage to employers and comments on 2024 rate notice HHS and CMS - request for information (RFI) - current essential health benefits guidance HHS, Labor and Treasury(the tri-agencies) - guidance on group health plan attestations to Gag clause prohibition HHS, Labor and Treasury(the tri-agencies) -clarification of air ambulance reporting deadline for group health plans HHS, Labor and Treasury(the tri-agencies) - prescription drug and health care cost reporting - submitted comments HHS, Labor and Treasury (the tri-agencies) - final surprise billing regulations on the independent dispute resolution (IDR) process HHS, Labor and Treasury (the tri-agencies) - request for information (RFI) - advanced explanation of benefits Treasury/IRS -Pre-Deductible Telehealth Care in High Deductible Health Plans HHS, Labor and Treasury (the tri-agencies) Mental health parity requirements for group health plans and insurers, including under the CAA HHS, Labor and Treasury (tri-agencies) - transparency provisions under the CAA HHS - Enforcement of Hospital Price Transparency Rules Treasury/IRS - request for guidance on repurposing of welfare benefit fund assets ERISA uniformity High Deductible Health Plans (HDHPs) Health Savings Accounts (HSAs) State health care requirements affecting self-insured plans Abortion coverage and travel benefits in health plans Employer mandate ERISA Preemption Preventative care
2022 · second_quarter · Civil Rights/Civil Liberties
Charitable Choice Issues Ensuring Fair Access to Disaster Relief for LGBTQ Families Executive Nominations Judicial Nominations Supreme Court Nomination LGBTQ Non-Discrimination Protections LGBTQ Data Collection Religious Liberty Issues Sexual Harassment and Violence Voting Rights Workplace Protections for Federal Contractors DC Statehood Implementation of Bostock ruling Combating Race and Sex Stereotyping EO Anti-LGBTQ Amendments in Appropriations 21st Century President Act (H.R. 3285) Amend the Code for Marriage Equality Act (H.R. 4170) BE HEARD in the Workplace Act (S. 3219, H.R. 5994) Bipartisan Background Checks Act (H.R. 8) Customer Non-Discrimination Act (H.R. 4023) District of Columbia Local Juror Nondiscrimination Act (H.R. 3787) Do No Harm Act (H.R. 1378, S. 2752) Eliminating the HHS Discrimination Division Act of 2021 (H.R. 4023) End Racial and Religious Profiling Act of 2021 (S. 579) Enhanced Background Checks Act (H.R. 1446) Equality Act (H.R. 5, S. 393) Ruthie and Connie LGBT Elder Americans Act (H.R. 7993) LGBTQI+ Data Inclusion Act (H.R. 4176, S. 2287) LGBTQ Essential Data Act (H.R. 3834) Violence Against Women Reauthorization Act of 2021 (H.R. 1620, S. 3623) Washington, D.C. Admission Act (H.R. 51, S. 51) Screening with Dignity Act (H.R. 4249) Don't Block LGBTQ Act (H.R. 8249) To award a Congressional Gold Medal to Billie Jean King, in recognition of her contribution to the Nation and her courageous and groundbreaking leadership advancing equal rights for women and the LGBTQ community in athletics, education, and our society (H.R. 4147) LGBTQ Business Equal Credit Enforcement and Investment Act (H.R. 1443) Designate the National Pulse Memorial (H.R. 49) John R. Lewis Voting Rights Advancement Act (H.R. 4, S. 4) Freedom to Vote Act (S.2747) Freedom to Vote: John R. Lewis Act (H.R. 5746) Fair Pay for All Act of 2021 (H.R. 6085) LGBTQ Business Equal Credit Enforcement and Investment Act (S. 4002) American Data Protection and Privacy Act (H.R. 8152)
2022 · first_quarter · Civil Rights/Civil Liberties
Charitable Choice Issues Ensuring Fair Access to Disaster Relief for LGBTQ Families Executive Nominations Judicial Nominations Supreme Court Nomination LGBTQ Non-Discrimination Protections LGBTQ Data Collection in Census Religious Liberty Issues, including License to Discriminate EO Sexual Harassment and Violence Voting Rights Workplace Protections for Federal Contractors DC Statehood Implementation of Bostock ruling Combating Race and Sex Stereotyping EO Anti-LGBTQ Amendments in Appropriations 21st Century President Act (H.R. 3285) A resolution encouraging the celebration of the month of June as LQBTQIA+ Pride Month". (H.Res. 489) A resolution recognizing June 2021 as 'LGBTQ Pride Month'. (S.Res. 261) Adopting the Rules of the House of Representatives for the One Hundred Sixteenth Congress, and for other purposes Amend the Code for Marriage Equality Act (H.R. 4170) BE HEARD in the Workplace Act (S. 3219, H.R. 5994) Bipartisan Background Checks Act (H.R. 8) Committing to elevate the voices, leadership, and needs of communities that face systemic barriers in the effort to end sexual violence and support all survivors... Customer Non-Discrimination Act (H.R. 5754) Disability Integration Act District of Columbia Non-Discrimination Home Rule Act (H.R. 4023) Do No Harm Act (H.R. 1378, S. 2752) Eliminating the HHS Discrimination Division Act (H.R. 4023) EMPOWER Act (H.R. 1312) End Racial and Religious Profiling Act (S.597) Enhanced Background Checks Act (H.R. 1446) Equality Act (H.R. 5, S. 393) Ruthie and Connie LGBT Elder Americans Act LGBTQ Data Inclusion Act (H.R. 4176, S. 2287) LGBTQ Essential Data Act (H.R. 3834) SAFE SEX Workers Study Act Violence Against Women Reauthorization Act (H.R. 1620) Washington, D.C. Admission Act (H.R. 51, S. 51) Screening with Dignity Act (H.R. 4249) Anthony Gonzales Equality for Survivors Act Equitable Data Collection and Disclosure on COVID-19 Act (H.R. 1370 and S. 512.) To award a Congressional Gold Medal to Billie Jean King, in recognition of her contribution to the Nation and her courageous and groundbreaking leadership advancing equal rights for women and the LGBTQ community in athletics, education, and our society ((H.R. 4147) LGBTQ Business Equal Credit Enforcement and Investment Act (H.R. 1443) Designate the National Pulse Memorial (H.R. 49) A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Equal Employment Opportunity Commission relating to "Update of Commission's Conciliation Procedures" (S.J.Res. 13) John R. Lewis Voting Rights Advancement Act (H.R. 4, S. 4) Recognizing Black History Month as an important time to celebrate the remarkable and unique contributions of all LGBTQ+ Black Americans in United States history (H. Res. 170) Freedom to Vote Act (S.2747) Freedom to Vote: John R. Lewis Act (H.R. 5746) Fair Pay for All Act of 2021 (H.R. 6085) LGBTQ Business Equal Credit Enforcement and Investment Act (S. 4002)
2021 · fourth_quarter · Civil Rights/Civil Liberties
Charitable Choice Issues Ensuring Fair Access to Disaster Relief for LGBTQ Families Executive Nominations Judicial Nominations Supreme Court Nomination LGBTQ Non-Discrimination Protections LGBTQ Data Collection in Census Religious Liberty Issues, including License to Discriminate EO Sexual Harassment and Violence Voting Rights Workplace Protections for Federal Contractors DC Statehood Implementation of Bostock ruling Combating Race and Sex Stereotyping EO Anti-LGBTQ Amendments in Appropriations 21st Century President Act (H.R. 3285) A resolution encouraging the celebration of the month of June as LQBTQIA+ Pride Month". (H.Res. 489) A resolution recognizing June 2021 as 'LGBTQ Pride Month'. (S.Res. 261) Adopting the Rules of the House of Representatives for the One Hundred Sixteenth Congress, and for other purposes Amend the Code for Marriage Equality Act (H.R. 4170) BE HEARD in the Workplace Act (S. 3219, H.R. 5994) Bipartisan Background Checks Act (H.R. 8) Committing to elevate the voices, leadership, and needs of communities that face systemic barriers in the effort to end sexual violence and support all survivors...etc. Customer Non-Discrimination Act (H.R. 5754) Disability Integration Act District of Columbia Non-Discrimination Home Rule Act (H.R. 4023) Do No Harm Act (H.R. 1378, S. 2752) Elder Pride Act Eliminating the HHS Discrimination Division Act (H.R. 4023) EMPOWER Act (H.R. 1312) End Racial and Religious Profiling Act (S.597) Enhanced Background Checks Act (H.R. 1446) Equality Act (H.R. 5, S. 393) Inclusive Aging Act Ruthie and Connie LGBT Elder Americans Act LGBTQ Data Inclusion Act (H.R. 4176, S. 2287) LGBTQ Essential Data Act (H.R. 3834) SAFE SEX Workers Study Act Violence Against Women Reauthorization Act (H.R. 1620) Washington, D.C. Admission Act (H.R. 51, S. 51) Screening with Dignity Act (H.R. 4249) Don't Block LGBTQ Act Anthony Gonzales Equality for Survivors Act Equitable Data Collection and Disclosure on COVID-19 Act (H.R. 1370 and S. 512.) To award a Congressional Gold Medal to Billie Jean King, in recognition of her contribution to the Nation and her courageous and groundbreaking leadership advancing equal rights for women and the LGBTQ community in athletics, education, and our society ((H.R. 4147) LGBTQ Business Equal Credit Enforcement and Investment Act (H.R. 1443) Designate the National Pulse Memorial (H.R. 49) A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Equal Employment Opportunity Commission relating to "Update of Commission's Conciliation Procedures" (S.J.Res. 13) John R. Lewis Voting Rights Advancement Act (H.R. 4, S. 4) Recognizing Black History Month as an important time to celebrate the remarkable and unique contributions of all LGBTQ+ Black Americans in United States history (H. Res. 170) Freedom to Vote Act (S.2747) Freedom to Vote: John R. Lewis Act (H.R. 5746) Fair Pay for All Act of 2021 (H.R. 6085)
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5700)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.
DEBATE - The House proceeded with forty minutes of debate on H.R. 3285.
Considered under suspension of the rules. (consideration: CR H5700-5701)
Mr. Cicilline moved to suspend the rules and pass the bill.
Placed on the Union Calendar, Calendar No. 291.
Reported by the Committee on Judiciary. H. Rept. 117-380.
Congress.gov source codes: 5000, H12200
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Subcommittee on Crime, Terrorism, and Homeland Security Discharged.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Referred to the House Committee on the Judiciary.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Markup by |
| June 15, 2022 |
| Judiciary Committee | House | Referred to | May 17, 2021 |
| June 21, 2022 |
| Introduced in House | May 17, 2021 |
| Enrolled Bill | -- |
| Democratic |
| IN |
| Andy Levin | Democratic | MI |
| Angie Craig | Democratic | MN |
| Bobby L. Rush | Democratic | IL |
| Bonnie Watson Coleman | Democratic | NJ |
| Carolyn B. Maloney | Democratic | NY |
| Chris Pappas | Democratic | NH |
| Darren Soto | Democratic | FL |
| David N. Cicilline | Democratic | RI |
| Debbie Dingell | Democratic | MI |
| Debbie Wasserman Schultz | Democratic | FL |
| Dina Titus | Democratic | NV |
| Donald M. Payne, Jr. | Democratic | NJ |
| Ed Case | Democratic | HI |
| Eleanor Holmes Norton | Democratic | DC |
| Frank Pallone, Jr. | Democratic | NJ |
| Gwen Moore | Democratic | WI |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Jackie Speier | Democratic | CA |
| Jake Auchincloss | Democratic | MA |
| James P. McGovern | Democratic | MA |
| Jamie Raskin | Democratic | MD |
| Janice D. Schakowsky | Democratic | IL |
| Jason Crow | Democratic | CO |
| Judy Chu | Democratic | CA |
| Lloyd Doggett | Democratic | TX |
| Lois Frankel | Democratic | FL |
| Mark Takano | Democratic | CA |
| Mary Gay Scanlon | Democratic | PA |
| Melanie A. Stansbury | Democratic | NM |
| Mondaire Jones | Democratic | NY |
| Nanette Diaz Barragán | Democratic | CA |
| Nikema Williams | Democratic | GA |
| Nydia M. Velázquez | Democratic | NY |
| Paul Tonko | Democratic | NY |
| Peter Welch | Democratic | VT |
| Raúl M. Grijalva | Democratic | AZ |
| Ritchie Torres | Democratic | NY |
| Ro Khanna | Democratic | CA |
| Salud O. Carbajal | Democratic | CA |
| Sara Jacobs | Democratic | CA |
| Sean Patrick Maloney | Democratic | NY |
| Seth Moulton | Democratic | MA |
| Sharice Davids | Democratic | KS |
| Sheila Jackson Lee | Democratic | TX |
| Stephen F. Lynch | Democratic | MA |
| Suzanne Bonamici | Democratic | OR |
| Theodore E. Deutch | Democratic | FL |
| Van Taylor | Republican | TX |
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Client expense: $6,300,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Client expense: $440,980 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
Client expense: $316,568 · Firm income: Not reported
Government targets: Education, Dept of, Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), White House Office
Client expense: $147,000 · Firm income: Not reported
Government targets: Education, Dept of, Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), White House Office
Client expense: $175,000 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Administration on Aging, Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl AIDS Policy, Office of Personnel Management (OPM), Office on Violence Against Women, SENATE, Social Security Administration (SSA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office